Aspirin was named as a potential drug to help treating the coronavirus infection. It will be tested in the RECOVERY study. To date, there are more than 59.8 million confirmed cases of the COVID-19 worldwide. Many countries began to re-impose tough restrictions amid rising disease rates, trying to develop new treatment regimens and antiviral therapies to block the infection. A new research led the scientists to an aspirin.
They believe that a daily pain reliever could be a potential remedy for the coronavirus. The aim of the study is to assess whether a drug can reduce the risk of blood clots in infected people. An aspirin was first released 120 years ago. It is mainly used to relieve pain, fever and inflammation.
Now, it will also be part of the world's largest study related to the treatment of patients with the COVID-19. It is carried out in 176 hospitals in the UK, where about 16 thousand patients diagnosed with the coronavirus are staying.
Other drugs are expected to be used during the treatment: tocilizumab, azithromycin, low-dose dexamethasone, convalescent plasma, monoclonal antibodies and aspirin. The dcientists believe that infected patients have overactive platelets.
They are small, colorless formations in the blood. They form clots and can stop or prevent bleeding. These patients are at high risk of fatal blood clots. The experts believe that aspirin can become a blood thinner and can help to reduce the likelihood of complications with blood clotting against the background of the coronavirus infection.
Peter Horby, who is a professor at Nuffield School of Medicine, believes that aspirin needs to be added to research because it can be safe, inexpensive, effective, and important. Whether it is such, the results of the study will show.